Ontology highlight
ABSTRACT: Background
It has been suggested that targeting prostate lesions identified on magnetic resonance imaging (MRI) will improve the sensitivity of prostate biopsy for high-grade disease. The clinical significance of high-grade tumors found on MRI but missed on systematic biopsy is open to question.Objective
To determine the risk of mortality for high-grade cancers identified by MRI targeting in men who had benign systematic biopsy findings.Design, setting, and participants
We used data from 999 men with negative systematic biopsy and concurrent MRI-targeted biopsy in the National Cancer Institute MRI study. The comparison group consisted of 3056 men followed for 11 yr after negative sextant biopsy in the European Randomized Trial of Screening for Prostate Cancer (ERSPC
SUBMITTER: Vickers AJ
PROVIDER: S-EPMC8530856 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature